What Is Enramycin? Definition and What Research Reports

Definition

Enramycin (also written enduracidin) is a fermentation-derived peptide antibiotic complex produced by the soil actinomycete Streptomyces fungicidicus. Chemically it belongs to the lipodepsipeptide family: a macrocyclic peptide backbone built from a number of unusual, non-proteinogenic amino acid residues and carrying a fatty acyl side chain, supplied as a mixture of two closely related congeners conventionally designated A and B. It is active mainly against Gram-positive bacteria, acts at the bacterial cell wall rather than on protein synthesis, and is very poorly absorbed from the gastrointestinal tract — which is why it has historically been used as an in-feed antibacterial and growth promoter in poultry and swine production in several countries rather than as a systemic human medicine. In the research literature summarised here, enramycin is encountered almost exclusively in that agricultural context.

What Class of Molecule Is It?

Enramycin is classified as a non-ribosomal peptide antibiotic. That places it in the same broad bucket as bacitracin, vancomycin, polymyxin and daptomycin: molecules assembled enzymatically by microbial non-ribosomal peptide synthetase machinery rather than translated from mRNA, and therefore rich in D-amino acids, cyclic linkages and residues that never appear in ordinary proteins. Practical consequences of that structure include resistance to digestive proteases, minimal systemic uptake after oral administration and activity confined largely to Gram-positive organisms.

It is important to separate this class from the therapeutic "peptides" that dominate consumer discussion. Enramycin is an antibiotic peptide of microbial origin, not a signalling peptide, hormone analogue or growth-factor fragment. It has no described receptor-mediated endocrine activity, and the cited literature does not evaluate it in humans.

Where It Comes From

Enramycin is obtained by controlled fermentation of Streptomyces fungicidicus followed by extraction and purification of the peptide complex. Streptomyces species are the single most productive genus of antibiotic-producing soil bacteria, and enramycin sits alongside many other secondary metabolites from that genus. Because it is a fermentation product rather than a synthetic molecule, commercial material is typically described as a standardised complex of the A and B components rather than a single pure chemical entity.

How the Term Is Used in Peptide and Animal-Nutrition Research

In published studies, "enramycin" most often appears not as the compound under investigation but as the reference arm — the antibiotic growth promoter against which a non-antibiotic alternative is measured. This design reflects the central question of modern production-animal nutrition: whether feed additives such as antimicrobial peptides, probiotics, prebiotics, organic acids, short-chain fatty acid derivatives or plant extracts can match the performance and gut-health outcomes historically obtained with in-feed antibiotics, at a time when antibiotic growth promoters are restricted or banned in many jurisdictions on antimicrobial-resistance grounds.

Readers scanning this literature will therefore see the term in methods sections describing dietary treatment groups, in tables of feed formulations, and in discussion sections weighing alternatives against conventional antibiotic controls. The outcomes actually measured are almost always zootechnical and microbiological: body weight gain, feed conversion ratio, intestinal villus architecture, caecal or ileal microbiome composition, immune and inflammatory markers, and carcass or meat-quality traits.

What the Published Literature Reports

The verified studies collected for this entry are animal-nutrition trials in broiler chickens, quails and weaned piglets that tested non-antibiotic additives in comparison with conventional antibiotic-supplemented or unsupplemented diets. Researchers in a 2024 broiler experiment examined alternatives to antimicrobial growth promoters in birds challenged with subclinical necrotic enteritis and reported performance and intestinal outcomes across dietary treatments (PMID 39003795). A separate 2024 comparison of plant extracts and probiotics in chickens with necrotic enteritis reported differences in growth and gut-health indicators between the tested additives (PMID 39595364), and a 2024 microbiome study reported that intestinal microbial profiles in broilers differed according to which probiotic strain was fed (PMID 39203481).

Antimicrobial peptides themselves have been studied in the same framework. The study of plectasin-supplemented broilers raised under tropical environmental conditions reported immunomodulatory responses in supplemented birds (PMID 33834298), which is the closest analogue in this set to a peptide-based additive being evaluated where an antibiotic would traditionally be used. Other work in the group tested non-peptide strategies: researchers reported that phytogenics and encapsulated sodium butyrate could serve as growth promoters for lightly weaned piglets in place of antibiotics (PMID 36548241), that chemically protected sodium butyrate improved growth performance and early small-intestinal development and function in broilers as a substitute for antibiotics (PMID 35203735), and that combining sodium butyrate with xylo-oligosaccharide affected growth performance, anti-inflammatory and antioxidant capacity, intestinal morphology and microbiota in early-stage broilers (PMID 36913758).

Plant- and acid-based comparators round out the picture. A 2021 trial reported regulatory effects of combined dietary essential oils and organic acids on the microbial communities of Cobb broilers (PMID 35046927), a 2020 study reported effects of dietary organic acids on performance, caecal microbiota and gut morphology in broilers (PMID 32939703), protocatechuic acid was reported to improve growth performance, meat quality and intestinal health in Chinese yellow-feathered broilers (PMID 30938807), and fermented and non-fermented Chinese chive juice was evaluated as an alternative to antibiotic growth promoters in broilers (PMID 36290128). In quails, researchers reported effects of Aloe vera and clove powder supplementation on growth performance, carcass traits and blood chemistry (PMID 35172233). Taken together, this body of work frames enramycin-type in-feed antibiotics as the historical benchmark that newer additives are asked to equal.

Typical study designs in which the term appears

Safety and Tolerability in the Cited Literature: What Studies Report

The verified studies in this entry are production-animal experiments whose endpoints were performance, intestinal morphology, microbiota and, in some cases, immune or blood-chemistry measures — for example the quail study that reported carcass and blood chemistry outcomes (PMID 35172233) and the broiler study that reported anti-inflammatory and antioxidant measures (PMID 36913758). None of them was a human safety or pharmacokinetic study, and no human adverse-event data for enramycin are represented in this set. This page is for educational purposes only and is not medical advice; consult a licensed physician about any question concerning a specific compound or health condition.

Terms Often Confused With Enramycin

• Enduracidin — the same peptide complex under its alternative name; the two terms are used interchangeably in the chemistry literature.
• Enrofloxacin — an unrelated veterinary fluoroquinolone, not a peptide.
• Bacitracin / avilamycin — other in-feed antibacterials that appear as comparator arms in the same field of research.
• Antimicrobial peptides (AMPs) — host-defence or engineered peptides such as plectasin studied as alternatives to in-feed antibiotics (PMID 33834298).

Limitations of the Evidence Summarised Here

Three limits are worth stating plainly. First, the cited evidence base is agricultural: outcomes such as feed conversion ratio and caecal microbiota composition in broilers do not transfer to human physiology. Second, these were comparative feeding trials, so results depend heavily on diet composition, housing, pathogen challenge and breed — the necrotic-enteritis challenge models are a clear example (PMID 39003795). Third, no dosing figures for enramycin are stated on this page because the verified source set does not support them, and regulatory status differs by country: antibiotic growth promoters are prohibited in feed in some jurisdictions and permitted in others, which is why so much of this literature is devoted to alternatives (PMID 36290128).

References

• Immunomodulatory responses in plectasin-supplemented broilers under tropical environmental conditions (Tropical Animal Health and Production, 2021)
• Intestinal Microbiome Profiles in Broiler Chickens Raised with Different Probiotic Strains (Microorganisms, 2024)
• Phytogenics and encapsulated sodium butyrate can replace antibiotics as growth promoters for lightly weaned piglets (PLoS One, 2022)
• Regulatory Effects of Combined Dietary Supplementation With Essential Oils and Organic Acids on Microbial Communities of Cobb Broilers (Frontiers in Microbiology, 2021)
• Alternative to antimicrobial growth promoters in the diets of broilers challenged with subclinical necrotic enteritis (Poultry Science, 2024)
• Protocatechuic acid improved growth performance, meat quality, and intestinal health of Chinese yellow-feathered broilers (Poultry Science, 2019)
• Evaluation of Non-Fermented and Fermented Chinese Chive Juice as an Alternative to Antibiotic Growth Promoters of Broilers (Animals, 2022)
• Comparative Efficacy of Plant Extracts and Probiotics on Growth and Gut Health in Chickens with Necrotic Enteritis (Animals, 2024)
• Chemically Protected Sodium Butyrate Improves Growth Performance and Early Development and Function of Small Intestine in Broilers as One Effective Substitute for Antibiotics (Antibiotics, 2022)
• Effect of Aloe vera and clove powder supplementation on growth performance, carcass and blood chemistry of Japanese quails (Poultry Science, 2022)
• Effects of dietary organic acids on performance, cecal microbiota, and gut morphology in broilers (Tropical Animal Health and Production, 2020)
• Combined effects of sodium butyrate and xylo-oligosaccharide on growth performance, anti-inflammatory and antioxidant capacity, intestinal morphology and microbiota of broilers at early stage (Poultry Science, 2023)